bf/NASDAQ:PAHC_icon.png

COM:PAHC

Phibro Animal Health Corporation

  • Stock

Last Close

23.39

21/11 21:00

Market Cap

663.85M

Beta: -

Volume Today

196.64K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Jun '14
Jun '15
Jun '16
Jun '17
Jun '18
Jun '19
Jun '20
Jun '21
Jun '22
Jun '23
Jun '24
average inventory
141.61M
-
146.49M
3.44%
158.74M
8.37%
164.46M
3.61%
169.70M
3.19%
188.25M
10.93%
197.49M
4.91%
206.49M
4.55%
237.74M
15.13%
268.36M
12.88%
271.74M
1.26%
average payables
58.76M
-
61.33M
4.39%
61.61M
0.46%
58.53M
5.00%
58.20M
0.57%
66.34M
14.00%
69.64M
4.97%
67.23M
3.47%
81.98M
21.94%
84.72M
3.35%
79.71M
5.92%
average receivables
106.50M
-
112.48M
5.62%
117.44M
4.42%
124.82M
6.28%
130.79M
4.79%
147.38M
12.68%
142.77M
3.13%
136.69M
4.26%
156.69M
14.64%
165.01M
5.31%
166.47M
0.88%
book value per share
0.47
-
0.76
61.61%
2.30
202.81%
3.83
66.22%
4.60
20.23%
5.35
16.22%
4.65
13.09%
5.89
26.82%
6.48
9.94%
6.97
7.65%
6.34
9.16%
capex per share
-0.62
-
-0.51
16.49%
-0.92
79.71%
-0.53
42.80%
-0.46
12.80%
-0.74
60.36%
-0.84
13.62%
-0.72
13.82%
-0.91
26.25%
-1.28
39.82%
1.02
179.62%
capex to depreciation
-0.93
-
-0.93
0.36%
-1.55
66.95%
-0.80
48.14%
-0.69
14.36%
-1.08
57.52%
-1.05
2.93%
-0.92
12.65%
-1.13
23.18%
-1.52
34.44%
1.14
174.85%
capex to operating cash flow
27.87
-
-0.29
101.05%
-0.98
234.56%
-0.21
78.25%
-0.26
24.74%
-0.63
139.19%
-0.57
9.48%
-0.61
5.81%
-1.17
92.84%
-3.89
232.46%
0.47
112.10%
capex to revenue
-0.03
-
-0.03
6.59%
-0.05
80.53%
-0.03
43.47%
-0.02
17.28%
-0.04
59.60%
-0.04
17.82%
-0.04
17.29%
-0.04
11.74%
-0.05
34.73%
0.04
176.51%
cash per share
0.37
-
0.75
104.22%
0.86
14.05%
1.42
66.04%
1.97
38.70%
2.02
2.53%
2.26
11.70%
2.30
2.11%
2.25
2.18%
2.01
10.92%
2.83
41.01%
days of inventory on hand
107.96
-
106.74
1.13%
119.43
11.89%
114.05
4.50%
117.58
3.09%
128.48
9.28%
132.07
2.79%
140.49
6.37%
144.00
2.50%
149.07
3.52%
137.63
7.67%
days payables outstanding
44.94
-
44.94
0.01%
42.85
4.64%
40.24
6.08%
39.26
2.44%
47.42
20.76%
44.38
6.39%
44.40
0.03%
53.12
19.64%
39.66
25.33%
44.29
11.67%
days sales outstanding
60.06
-
54.17
9.81%
60.12
10.99%
60.10
0.04%
60.42
0.54%
70.10
16.02%
57.70
17.69%
64.32
11.47%
64.51
0.30%
61.02
5.41%
60.78
0.40%
debt to assets
0.61
-
0.59
4.21%
0.58
1.54%
0.50
13.07%
0.47
7.41%
0.45
3.49%
0.52
16.70%
0.51
3.17%
0.50
0.44%
0.52
3.96%
0.50
3.90%
debt to equity
19.10
-
9.77
48.85%
3.90
60.11%
2.07
46.86%
1.69
18.47%
1.51
10.60%
2.18
44.53%
1.79
18.03%
1.79
0.21%
1.81
0.69%
1.93
6.97%
dividend yield
0.04
-
0.01
70.95%
0.02
108.42%
0.01
49.51%
0.01
19.72%
0.01
67.63%
0.02
25.40%
0.02
8.92%
0.03
50.94%
0.04
39.64%
0.03
19.60%
earnings yield
-0.00
-
0.04
1,005.70%
0.11
183.89%
0.04
60.86%
0.04
20.58%
0.04
22.14%
0.03
26.25%
0.05
47.37%
0.06
36.43%
0.06
7.46%
0.00
94.04%
enterprise value
984.36M
-
1.78B
80.60%
1.05B
40.80%
1.72B
63.48%
2.13B
24.06%
1.55B
27.57%
1.44B
6.97%
1.55B
7.44%
1.17B
24.22%
1.02B
12.59%
1.15B
11.86%
enterprise value over ebitda
15.40
-
16.23
5.37%
12.27
24.43%
17.57
43.27%
21.58
22.80%
18.54
14.10%
20.78
12.12%
20.63
0.73%
14.82
28.15%
9.44
36.35%
11.61
23.09%
ev to operating cash flow
-1.38K
-
25.88
101.87%
28.28
9.28%
17.49
38.17%
30.49
74.37%
32.78
7.51%
24.24
26.06%
31.99
32.00%
37.00
15.66%
76.90
107.84%
13.07
83.00%
ev to sales
1.42
-
2.37
66.92%
1.40
41.03%
2.25
60.74%
2.60
15.63%
1.87
28.27%
1.80
3.76%
1.85
3.19%
1.24
32.98%
1.05
15.78%
1.13
7.49%
free cash flow per share
-0.64
-
1.25
295.53%
0.02
98.23%
1.96
8,803.88%
1.28
34.76%
0.43
66.59%
0.62
46.08%
0.47
24.92%
-0.13
128.39%
-0.95
613.33%
1.14
220.46%
free cash flow yield
-0.03
-
0.03
210.22%
0.00
96.32%
0.05
4,384.38%
0.03
47.51%
0.01
51.34%
0.02
75.84%
0.02
31.70%
-0.01
142.87%
-0.07
896.05%
0.07
196.84%
graham net net
-8.96
-
-7.09
20.84%
-7.88
11.13%
-6.11
22.50%
-5.39
11.72%
-5.21
3.26%
-7.69
47.43%
-7.20
6.38%
-7.99
10.98%
-8.55
7.01%
-8.66
1.35%
graham number
1.01
-
5.14
409.57%
10.44
102.96%
11.87
13.66%
12.93
8.94%
12.76
1.28%
9.31
27.02%
13.35
43.34%
13.31
0.32%
11.24
15.54%
2.92
74.06%
income quality
0.23
-
1.14
400.56%
0.45
60.53%
1.52
238.50%
1.08
29.15%
0.86
20.10%
1.77
105.17%
0.89
49.78%
0.64
27.54%
0.41
36.57%
36.26
8,781.72%
intangibles to total assets
0.09
-
0.10
12.62%
0.13
31.56%
0.13
5.26%
0.12
6.31%
0.10
12.81%
0.16
53.18%
0.14
13.37%
0.13
8.03%
0.11
11.32%
0.10
9.02%
interest coverage
1.93
-
6.02
211.57%
5.16
14.29%
6.57
27.27%
8.31
26.49%
6.21
25.26%
2.86
54.00%
3.33
16.70%
3.89
16.67%
4.00
2.89%
2.84
29.02%
interest debt per share
10.01
-
7.80
22.07%
9.40
20.43%
8.30
11.62%
8.07
2.87%
8.37
3.71%
10.46
25.03%
10.86
3.84%
11.91
9.65%
13.03
9.44%
12.78
1.97%
inventory turnover
3.38
-
3.42
1.14%
3.06
10.63%
3.20
4.72%
3.10
3.00%
2.84
8.49%
2.76
2.72%
2.60
5.99%
2.53
2.44%
2.45
3.40%
2.65
8.31%
invested capital
19.10
-
9.77
48.85%
3.90
60.11%
2.07
46.86%
1.69
18.47%
1.51
10.60%
2.18
44.53%
1.79
18.03%
1.79
0.21%
1.81
0.69%
737.34M
40,847,043,347.41%
market cap
706.79M
-
1.52B
114.70%
733.34M
51.67%
1.46B
99.56%
1.85B
26.49%
1.28B
30.99%
1.06B
16.71%
1.17B
9.86%
774.84M
33.71%
554.90M
28.38%
690.19M
24.38%
net current asset value
-157.88M
-
-149.96M
5.02%
-177.06M
18.07%
-108.58M
38.68%
-71.26M
34.36%
-44.49M
37.56%
-144.06M
223.77%
-103.89M
27.89%
-103.03M
0.83%
-103.17M
0.14%
-124.55M
20.73%
net debt to ebitda
4.34
-
2.38
45.28%
3.72
56.48%
2.63
29.40%
2.86
9.06%
3.22
12.47%
5.41
67.98%
5.03
7.09%
5.02
0.22%
4.32
13.87%
4.61
6.78%
net income per share
-0.10
-
1.55
1,706.75%
2.10
36.04%
1.64
22.28%
1.61
1.28%
1.35
16.13%
0.83
38.73%
1.34
62.01%
1.21
9.63%
0.81
33.73%
0.06
92.59%
operating cash flow per share
-0.02
-
1.76
8,073.31%
0.95
46.28%
2.49
163.05%
1.74
30.09%
1.17
32.96%
1.47
25.51%
1.19
18.55%
0.78
34.53%
0.33
57.94%
2.16
558.11%
payables turnover
8.12
-
8.12
0.01%
8.52
4.87%
9.07
6.48%
9.30
2.50%
7.70
17.19%
8.22
6.83%
8.22
0.03%
6.87
16.41%
9.20
33.92%
8.24
10.45%
receivables turnover
6.08
-
6.74
10.88%
6.07
9.90%
6.07
0.04%
6.04
0.53%
5.21
13.81%
6.33
21.50%
5.68
10.29%
5.66
0.30%
5.98
5.72%
6.01
0.40%
research and ddevelopement to revenue
0.03
-
return on tangible assets
-0.01
-
0.14
1,985.24%
0.16
14.97%
0.12
24.13%
0.11
7.60%
0.08
23.41%
0.05
39.37%
0.07
47.21%
0.06
19.36%
0.04
37.45%
0.00
92.75%
revenue per share
21.49
-
19.21
10.60%
19.12
0.46%
19.35
1.19%
20.40
5.42%
20.50
0.48%
19.76
3.57%
20.59
4.19%
23.26
12.98%
24.14
3.78%
25.13
4.07%
roe
-0.20
-
2.03
1,094.24%
0.91
55.08%
0.43
53.24%
0.35
17.89%
0.25
27.84%
0.18
29.50%
0.23
27.75%
0.19
17.80%
0.12
38.44%
0.01
91.84%
roic
-0.10
-
0.21
303.94%
0.21
0.84%
0.17
18.84%
0.15
13.42%
0.10
29.40%
0.04
65.45%
0.05
40.71%
0.04
18.84%
0.05
28.29%
0.02
64.92%
sales general and administrative to revenue
shareholders equity per share
0.47
-
0.76
61.61%
2.30
202.81%
3.83
66.22%
4.60
20.23%
5.35
16.22%
4.65
13.09%
5.89
26.82%
6.48
9.94%
6.97
7.65%
6.34
9.16%
stock based compensation to revenue
0.01
-
-0.00
144.61%
-0.01
127.94%
-0.16
1,443.78%
-0.00
99.51%
0.00
452.31%
0.00
3.45%
0.00
52.00%
-0.01
-
0.00
104.39%
tangible asset value
-27.27M
-
-20.27M
25.68%
9.26M
145.71%
72.57M
683.39%
105.63M
45.55%
141.19M
33.67%
64.53M
54.30%
123.57M
91.50%
145.35M
17.63%
174.25M
19.88%
157.05M
9.87%
tangible book value per share
-0.85
-
-0.52
38.59%
0.24
145.33%
1.84
679.42%
2.63
43.01%
3.49
33.00%
1.59
54.41%
3.05
91.62%
3.59
17.54%
4.30
19.88%
3.88
9.87%
working capital
186.85M
-
202.40M
8.32%
234.16M
15.69%
247.87M
5.86%
272.24M
9.83%
311.94M
14.58%
294.60M
5.56%
334.79M
13.64%
375.40M
12.13%
409.72M
9.14%
396.85M
3.14%

All numbers in (except ratios and percentages)